These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2969667)

  • 1. Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusion.
    Virmani R; Kolodgie FD; Osmialowski A; Zimmerman P; Mergner W; Forman MB
    Am Heart J; 1988 Aug; 116(2 Pt 1):421-31. PubMed ID: 2969667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions.
    Tokioka H; Miyazaki A; Fung P; Rajagopalan RE; Kar S; Meerbaum S; Corday E; Drury JK
    Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
    Cleman M; Jaffee CC; Wohlgelernter D
    Circulation; 1986 Sep; 74(3):555-62. PubMed ID: 2943533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol.
    Schaer GL; Krucoff MW; Green C; Visner MS
    Am Heart J; 1989 Oct; 118(4):679-85. PubMed ID: 2529747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%.
    Jaffe CC; Wohlgelernter D; Cabin H; Bowman L; Deckelbaum L; Remetz M; Cleman M
    Am Heart J; 1988 Jun; 115(6):1156-64. PubMed ID: 2967624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs.
    Kolodgie FD; Dawson AK; Forman MB; Virmani R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 50(2):119-34. PubMed ID: 2868560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%).
    Kolodgie FD; Virmani R; Farb A
    J Am Coll Cardiol; 1991 Jul; 18(1):215-23. PubMed ID: 2050924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against ischemia during prolonged balloon inflation by distal coronary perfusion with use of an autoperfusion catheter or Fluosol.
    Robalino BD; Marwick T; Lafont A; Vaska K; Whitlow PL
    J Am Coll Cardiol; 1992 Nov; 20(6):1378-84. PubMed ID: 1430688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
    Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
    Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does intracoronary infusion of Fluosol-DA 20% prevent left ventricular diastolic dysfunction during coronary balloon angioplasty?
    Bell MR; Nishimura RA; Holmes DR; Bailey KR; Schwartz RS; Vlietstra RE
    J Am Coll Cardiol; 1990 Oct; 16(4):959-66. PubMed ID: 2212378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model.
    Forman MB; Puett DW; Wilson BH; Vaughn WK; Friesinger GC; Virmani R
    J Am Coll Cardiol; 1987 May; 9(5):1082-90. PubMed ID: 3571747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of perfluorochemical fluosol-DA (20%) on myocardial infarct healing in the rabbit.
    Virmani R; Osmialowski AF; Kolodgie FD; Forman MB
    Am J Cardiovasc Pathol; 1990; 3(1):69-80. PubMed ID: 2331363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol.
    Kent KM; Cleman MW; Cowley MJ; Forman MB; Jaffe CC; Kaplan M; King SB; Krucoff MW; Lassar T; McAuley B
    Am J Cardiol; 1990 Aug; 66(3):279-84. PubMed ID: 2195864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leukocytes.
    Kolodgie FD; Farb A; Carlson GC; Wilson PS; Virmani R
    J Am Coll Cardiol; 1994 Oct; 24(4):1098-108. PubMed ID: 7930204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion.
    Forman MB; Puett DW; Bingham SE; Virmani R; Tantengco MV; Light RT; Bajaj A; Price R; Friesinger G
    Circulation; 1987 Aug; 76(2):469-79. PubMed ID: 3608128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorochemical perfusion during coronary angioplasty in unstable and high-risk patients.
    Cowley MJ; Snow FR; DiSciascio G; Kelly K; Guard C; Nixon JV
    Circulation; 1990 Mar; 81(3 Suppl):IV27-34. PubMed ID: 2306847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion.
    Forman MB; Bingham S; Kopelman HA; Wehr C; Sandler MP; Kolodgie F; Vaughn WK; Friesinger GC; Virmani R
    Circulation; 1985 May; 71(5):1060-8. PubMed ID: 3986976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioplegic protection with hypothermic K-Fluosol DA and K/Mg-Fluosol DA solutions.
    Kyösola K; Harjula A; Mattila S; Aalto-Setälä K; Mattila I; Mattila P; Salmenperä M; Merikallio E
    Scand J Thorac Cardiovasc Surg; 1985; 19(3):267-72. PubMed ID: 4081676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal coronary artery perfusion during percutaneous transluminal coronary angioplasty.
    Anderson HV; Leimgruber PP; Roubin GS; Nelson DL; Gruentzig AR
    Am Heart J; 1985 Oct; 110(4):720-6. PubMed ID: 2931968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygenated fluosol DA-20% distal infusion during coronary angioplasty protects myocardial function.
    Jaffe CC; Wohlgelernter D; Highman HA; Cleman M
    Prog Clin Biol Res; 1986; 211():21-7. PubMed ID: 2938192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.